Meng CF et al. |
Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells. |
2010 |
Cancer Invest. |
pmid:19857042
|
Fang Y et al. |
Synergistic efficacy in human ovarian cancer cells by histone deacetylase inhibitor TSA and proteasome inhibitor PS-341. |
2011 |
Cancer Invest. |
pmid:21345073
|
Khan AN et al. |
An epigenetically altered tumor cell vaccine. |
2004 |
Cancer Immunol. Immunother. |
pmid:14997346
|
Khan AN et al. |
Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells. |
2008 |
Cancer Immunol. Immunother. |
pmid:18046553
|
Tiper IV and Webb TJ |
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma. |
2016 |
Cancer Immunol. Immunother. |
pmid:27614429
|
Neumann F et al. |
EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors. |
2013 |
Cancer Immunol. Immunother. |
pmid:23619976
|
Mazzio EA and Soliman KFA |
Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A. |
|
Cancer Genomics Proteomics |
pmid:30194076
|
Mazzio EA and Soliman KF |
HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells. |
2017 |
Cancer Genomics Proteomics |
pmid:28031235
|
Shin S et al. |
Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes. |
|
Cancer Genomics Proteomics |
pmid:28871002
|
Zhou X et al. |
The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma. |
2007 |
Cancer Genet. Cytogenet. |
pmid:17693185
|
Wunder T et al. |
Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection. |
2013 |
Cancer Gene Ther. |
pmid:23196273
|
El-Zawahry A et al. |
In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL. |
2006 |
Cancer Gene Ther. |
pmid:16167063
|
Katsura T et al. |
The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells. |
2009 |
Cancer Gene Ther. |
pmid:18949013
|
Yoshida M et al. |
Histone deacetylase as a new target for cancer chemotherapy. |
2001 |
Cancer Chemother. Pharmacol. |
pmid:11587361
|
Bovenzi V and Momparler RL |
Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. |
2001 |
Cancer Chemother. Pharmacol. |
pmid:11488527
|
Whang YM et al. |
Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells. |
2005 |
Cancer Chemother. Pharmacol. |
pmid:15959780
|
Kang J et al. |
Synergistic killing of human leukemia cells by antioxidants and trichostatin A. |
2004 |
Cancer Chemother. Pharmacol. |
pmid:15248029
|
Fandy TE and Srivastava RK |
Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins. |
2006 |
Cancer Chemother. Pharmacol. |
pmid:16435155
|
Yamashita K et al. |
Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. |
2002 |
Cancer Cell |
pmid:12498717
|
Gius D et al. |
Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. |
2004 |
Cancer Cell |
pmid:15488759
|
Maecker HL et al. |
Epigenetic changes in tumor Fas levels determine immune escape and response to therapy. |
2002 |
Cancer Cell |
pmid:12204534
|
Jiang X et al. |
DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. |
2008 |
Cancer Cell |
pmid:18538736
|
Brugarolas JB et al. |
TSC2 regulates VEGF through mTOR-dependent and -independent pathways. |
2003 |
Cancer Cell |
pmid:12957289
|
Tuncel M et al. |
The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. |
2007 |
Cancer Biother. Radiopharm. |
pmid:17600477
|
Tuncel M et al. |
The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. |
2007 |
Cancer Biother. Radiopharm. |
pmid:17679169
|
Cao QF et al. |
TRPM2 mediates histone deacetylase inhibition-induced apoptosis in bladder cancer cells. |
2015 |
Cancer Biother. Radiopharm. |
pmid:25760728
|
Tang X et al. |
Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer. |
2012-2013 |
Cancer Biomark |
pmid:23321465
|
Trtková K et al. |
Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor. |
2010 |
Cancer Biomark |
pmid:21178266
|
El-Awady RA et al. |
Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy. |
2015 |
Cancer Biol. Ther. |
pmid:25962089
|
Lo PK et al. |
Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. |
2006 |
Cancer Biol. Ther. |
pmid:16410723
|
Taghiyev AF et al. |
TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome. |
2006 |
Cancer Biol. Ther. |
pmid:17110788
|
David GL et al. |
MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine. |
2004 |
Cancer Biol. Ther. |
pmid:15034303
|
Sangster-Guity N et al. |
Molecular profiling of embryonal carcinoma cells following retinoic acid or histone deacetylase inhibitor treatment. |
2004 |
Cancer Biol. Ther. |
pmid:15467438
|
Song K et al. |
Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1, a novel epithelial-mesenchymal transition inducer in pancreatic cancer. |
2011 |
Cancer Biol. Ther. |
pmid:21709440
|
Karagiannis TC et al. |
The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X. |
2005 |
Cancer Biol. Ther. |
pmid:16082178
|
Mazzarelli P et al. |
Carnitine palmitoyltransferase I in human carcinomas: a novel role in histone deacetylation? |
2007 |
Cancer Biol. Ther. |
pmid:18253084
|
Keen JC et al. |
Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells. |
2004 |
Cancer Biol. Ther. |
pmid:15662126
|
Ranganathan P and Rangnekar VM |
Exploiting the TSA connections to overcome apoptosis-resistance. |
2005 |
Cancer Biol. Ther. |
pmid:15908800
|
Taghiyev AF et al. |
Trichostatin A (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatment. |
2005 |
Cancer Biol. Ther. |
pmid:15846101
|
Chatterjee N et al. |
Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cells. |
2013 |
Cancer Biol. Ther. |
pmid:23792638
|
Anantharaju PG et al. |
Naturally occurring benzoic acid derivatives retard cancer cell growth by inhibiting histone deacetylases (HDAC). |
2017 |
Cancer Biol. Ther. |
pmid:28506198
|
Chakravarty G et al. |
Cytoplasmic compartmentalization of SOX9 abrogates the growth arrest response of breast cancer cells that can be rescued by trichostatin A treatment. |
2011 |
Cancer Biol. Ther. |
pmid:21084857
|
Honda H et al. |
Regulation of the CLDN3 gene in ovarian cancer cells. |
2007 |
Cancer Biol. Ther. |
pmid:17986852
|
Zhang XH et al. |
Aurora A, Aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer. |
2008 |
Cancer Biol. Ther. |
pmid:18708766
|
Zhang F et al. |
Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells. |
2009 |
Cancer Biol. Ther. |
pmid:19270532
|
Dowling M et al. |
Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents. |
2005 |
Cancer Biol. Ther. |
pmid:15753652
|
Pan L et al. |
Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. |
2007 |
Cancer |
pmid:17330857
|
Tan L et al. |
Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells. |
2011 |
Cancer |
pmid:20925046
|
Chen MY et al. |
Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy. |
2011 |
Cancer |
pmid:21491416
|
Kim MK and Carroll WL |
Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2. |
2004 |
Cancer |
pmid:15382088
|